Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019
August 28 2019 - 8:00AM
Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene
therapy company focused on developing life-changing treatments for
severe neurological diseases, today announced management
presentations at the following upcoming investor conferences in
September:
- Wells Fargo Securities Healthcare Conference, Boston,
MA Date: Wednesday, September 4,
2019 Presentation Time: 9:40 a.m. EDT
- HC Wainwright Healthcare Conference, New York,
NY Date: Monday, September 9,
2019 Presentation Time: 8:45 a.m. EDT
- Morgan Stanley Global Healthcare Conference, New York,
NY Date: Tuesday, September 10,
2019 Presentation Time: 2:05 p.m. EDT
Live-streaming webcasts of the presentations can
be accessed through the Investors & Media section of Voyager’s
website at www.voyagertherapeutics.com. The webcasts will be
archived for 30 days after the live events conclude.
About Voyager Therapeutics
Voyager Therapeutics is a clinical-stage
gene therapy company focused on developing life-changing treatments
for severe neurological diseases. Voyager is committed to advancing
the field of AAV gene therapy through innovation and investment in
vector engineering and optimization, manufacturing, and dosing and
delivery techniques. Voyager’s wholly-owned and partnered pipeline
focuses on severe neurological diseases for which effective new
therapies are needed, including Parkinson’s disease, Huntington’s
disease, a monogenic form of ALS called SOD1, Friedreich’s ataxia,
Alzheimer’s disease, and other neurodegenerative diseases related
to defective or excess aggregation of tau and alpha-synuclein
proteins in the brain. Voyager has strategic collaborations
with AbbVie and Neurocrine Biosciences. Founded by scientific and
clinical leaders in the fields of AAV gene therapy, expressed RNA
interference and neuroscience, Voyager is headquartered in
Cambridge, Massachusetts. For more information on Voyager, please
visit the company’s website at www.voyagertherapeutics.com or
follow @VoyagerTx on Twitter and LinkedIn.
Voyager Therapeutics® is a registered trademark
of Voyager Therapeutics.
Investor Relations: Allison
DorvalChief Financial
Officer857-856-4145investors@voyagertherapeutics.com
Media:
Sheryl SeapyW2O Group949-903-4750sseapy@w2ogroup.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Sep 2023 to Sep 2024